XTX Topco’s Tango Therapeutics TNGX Stock Holding History

XTX Topco’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$295K	Sell	14,095 -23,743	-63%	-$330K	0.01%	2497
2025 Q4	$335K	Buy	+37,838	New	+$326K	0.01%	1970
2025 Q3	–	Sell	-55,806	Closed	-$286K	–	3284
2025 Q2	$286K	Sell	55,806 -112,339	-67%	-$278K	0.01%	1470
2025 Q1	$230K	Buy	168,145 +90,208	+116%	+$222K	0.01%	1599
2024 Q4	$241K	Buy	77,937 +33,746	+76%	+$157K	0.02%	1404
2024 Q3	$340K	Buy	44,191 +34,150	+340%	+$326K	0.02%	1102
2024 Q2	$86.2K	Sell	10,041 -4,393	-30%	-$33.9K	0.01%	1439
2024 Q1	$115K	Buy	+14,434	New	+$155K	0.02%	1338
2023 Q2	–	Sell	-11,136	Closed	-$44K	–	1847
2023 Q1	$44K	Buy	+11,136	New	+$64.6K	0.01%	1179
2022 Q3	–	Sell	-34,569	Closed	-$157K	–	1390
2022 Q2	$157K	Buy	+34,569	New	+$209K	0.06%	529

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

XTX Topco's TNGX Position: Q1 2026 in Review

XTX Topco reduced its Tango Therapeutics (TNGX) stake by 63% in Q1 2026, selling an estimated $330K and leaving 14,095 shares worth $295K. The position accounts for 0.01% of the portfolio, ranked #2497.

XTX Topco first reported a position in TNGX in Q2 2022 and has held it in 10 quarters since. The position peaked at $340K in Q3 2024. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

XTX Topco held 14,095 shares of Tango Therapeutics worth $295K as of Q1 2026.
XTX Topco sold 23,743 Tango Therapeutics shares in Q1 2026, an estimated $330K.
Tango Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2497 holding.
XTX Topco first reported a position in Tango Therapeutics in Q2 2022 and has held it in 10 quarters since.
XTX Topco's Tango Therapeutics position peaked at $340K in Q3 2024.
194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.